CRNX vs PEP · rev $35.9M vs P/E 22, rev $43.62B
Crinetics Pharmaceuticals Inc (CRNX) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
CRNX currently screens at market cap $2.76B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the CRNX and PEP stock pages for the full models.
Not investment advice.